Huang et al. [166] developed two potent FTO inhibitors, FB23 and FB23-2, two tricyclic benzoic acids, which directly bind FTO and selectively block its m6A demethylase activity, significantly inhibiting the proliferation of AML cell lines and primary maternal AML cells. The gene discussed is FTO; the disease is acute myeloid leukemia.